Disease: Transient Ischemic Attack ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack. 30974489 2019
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE We sought to explore whether decreased kidney function alters the association between CYP2C19 genetic variants and clinical outcome in patients with minor stroke or transient ischemic attack (TIA) receiving clopidogrel therapy. 29520080 2018
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE We thus aim to conduct a meta-analysis to appraise evidence on the association of CYP2C19 genotype and clinical efficacy for stroke or TIA. 29901608 2018
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE Carriers of CYP2C19 loss-of-function alleles are at greater risk of stroke and composite vascular events than noncarriers among patients with ischemic stroke or TIA treated with clopidogrel. 27806998 2017
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE To estimate the association between CYP2C19 genetic variants and clinical outcomes of clopidogrel-treated patients with minor stroke or transient ischemic attack. 27348249 2016
CUI: C0007787
Disease: Transient Ischemic Attack
Transient Ischemic Attack 		0.060 GeneticVariation disease BEFREE A retrospective review of all patients with stroke and transient ischemic attack (TIA) tested for the clopidogrel CYP2C19 genotype was performed, with a collection of data including race/ethnicity, CYP2C19 status, and the presence of recurrent vascular events. 23849748 2014